Pomalidomide(pomalyst) 4MG cap

Ended Awarded Last action

Contract number
36C24526N0740
Awardee
Awarding agency
Obligated
$16,422

Award facts

Contract value 100% obligated
$16,421.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Memphis, TN 38141, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on July 15, 2026, for Pomalidomide (Pomalyst) 4 mg capsules with a ceiling value of $16,421.95 under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The call closes July 21, 2026. Place of performance is Memphis, Tennessee. Bristol-Myers Squibb supplies specialized oncology and hematology pharmaceuticals to the Department of Veterans Affairs on a full-and-open basis with no small business set-aside designations.

Quick answers

Who was awarded contract 36C24526N0740?

36C24526N0740 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 15, 2026.

How much is contract 36C24526N0740 worth?

The government has obligated $16,422 on 36C24526N0740.

Is contract 36C24526N0740 an order under another contract?

Yes. 36C24526N0740 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0740 competed?

The extent of competition for 36C24526N0740 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award